Crescent Biopharma (CBIO) Operating Margin (2013 - 2026)
Crescent Biopharma (CBIO) operating margin from Mar 31, 2013 to Mar 31, 2026. The current Crescent Biopharma (CBIO) operating margin is -2377.88%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Crescent Biopharma (CBIO)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -1408.03% | -99.64% |
| 2023 | -392800.00% | +562.95% |
| 2022 | -59250.00% | +983.22% |
| 2021 | -5469.83% | +978.89% |
| 2020 | -506.99% | -99.68% |
| 2016 | -159550.00% | N/A |
| 2016 | 0.00% | -100.00% |
| 2015 | -63.68% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | -74.12% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | -265.91% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | -100.00% |
| 2012 | 23.85% | N/A |
Comparison Crescent Biopharma (CBIO) operating margin with competitors
Crescent Biopharma (CBIO) operating margin is -2377.88%.